Pulmonary Disease clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
open to eligible people ages 46 years and up
DECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm). Molecular biomarkers for lung cancer diagnosis measured in minimally invasive and non-invasive biospecimens may be able to distinguish between malignant or benign indeterminate pulmonary nodules in high-risk smokers. Ultimately, this study aims to validate molecular as well as clinical and imaging biomarkers of lung cancer in individuals with indeterminate lung nodules.
Our lead scientists for Pulmonary Disease research studies include Denise Aberle, MD.